Toda, Japan

Ryo Muramatsu

This inventor holds 2 USPTO granted patents. Top assignees: Fuji Yakuhin Kogyo Kabushiki Kaisha, Japan Energy Corporation, Nippon Mining Co., Ltd.. Active years: 1998-1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ryo Muramatsu. Retrieved from https://idiyas.com/inventor/ryo-muramatsu-uxscd2r5

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1998-1999

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Ryo Muramatsu: Innovator in Anticoagulant Research

Introduction

Ryo Muramatsu is a notable inventor based in Toda, Japan. He has made significant contributions to the field of anticoagulant research, particularly through his innovative work on hirudin variants. With a total of two patents to his name, Muramatsu's inventions are paving the way for advancements in medical treatments.

Latest Patents

Muramatsu's latest patents focus on anticoagulant hirudin variants and methods for their production. These inventions relate to hirudin variants that exhibit high anti-thrombin and anti-platelet activity. The patents detail methods for producing these variants, which include sulfating the hydroxyl group of tyrosine residues. The anti-coagulants developed from these variants serve as active ingredients in medical applications.

Career Highlights

Throughout his career, Ryo Muramatsu has worked with prominent companies such as Fuji Yakuhin Kogyo Kabushiki Kaisha and Nippon Mining Co., Ltd. His experience in these organizations has contributed to his expertise in the field of biochemistry and pharmaceutical innovations.

Collaborations

Muramatsu has collaborated with notable coworkers, including Eriko Nukui and Koichi Wada. These partnerships have likely enhanced his research and development efforts in creating effective anticoagulant therapies.

Conclusion

Ryo Muramatsu's work in developing hirudin variants represents a significant advancement in anticoagulant research. His contributions are essential for the future of medical treatments aimed at improving patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…